A phase 2a evaluate the effect of AR882 alone or in combination with allopurinol or febuxostat on circulating levels and urinary excretion of hypoxanthine, xanthine and uric acid in patient with gout
Latest Information Update: 19 Jun 2021
At a glance
- Drugs AR 882 (Primary) ; Allopurinol; Febuxostat
- Indications Gout
- Focus Pharmacokinetics
- 19 Jun 2021 New trial record
- 05 Jun 2021 Results presented at the 22nd Annual Congress of the European League Against Rheumatism